Full-Time

Senior Associate Scientist-Bioassay

Posted on 1/15/2025

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

10,001+ employees

Develops medicines for serious diseases

Biotechnology
Healthcare

Compensation Overview

$79.1k - $129.1kAnnually

Mid, Senior

Tarrytown, NY, USA

Category
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • BS/MS degree
  • Minimum of 3-5 years of relevant experience
  • Experience with mammalian cell culture
  • Experience with cell engineering and validation
  • Experience with cell-based assay development
  • Ability to work collaboratively
  • Ability to multi-task with attention to details
  • Excellent verbal and written communication skills
Responsibilities
  • Culturing mammalian cells and engineering cell lines via transfection, transduction and CRISPR
  • Characterizing cells and reagents by flow cytometry, immunocytochemistry and immunoblotting
  • Developing cell-based bioassays and using them to screen antibodies in 96-well and 384-well plate formats
  • Analyzing data and troubleshooting experiments
  • Maintaining accurate and reliable records including electronic notebooks and all other pertinent documentation
  • Presenting data in small and large group settings
Desired Qualifications
  • Experience with flow cytometry
  • Experience with high throughput assays
  • Experience with therapeutic antibody development
  • Experience with primary immune cell assays
  • Experience with effector function assays
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

View

Regeneron Pharmaceuticals develops medicines aimed at treating serious diseases such as cancer, eye diseases, and allergic conditions. The company uses its own technologies and extensive research to create new therapies, often collaborating with academic institutions and other pharmaceutical companies to enhance its development efforts. Unlike many competitors, Regeneron focuses on both research and commercialization, generating revenue through the sale of its approved medicines and licensing its technologies. The goal of Regeneron is to improve patient outcomes by providing effective treatments and ensuring that its products meet high safety and efficacy standards.

Company Stage

IPO

Total Funding

$684M

Headquarters

Town of Greenburgh, New York

Founded

1988

Simplify Jobs

Simplify's Take

What believers are saying

  • Regeneron's investment in Truveta enhances its genomic data capabilities for personalized medicine.
  • The Oxular acquisition expands Regeneron's portfolio in retinal disorder treatments.
  • Dupixent's FDA review for CSU could open a new revenue stream for Regeneron.

What critics are saying

  • Class action lawsuits may lead to financial liabilities and reputational damage.
  • Investment in Truveta may not yield expected financial returns.
  • Competition from AstraZeneca and Amgen could impact Regeneron's market share.

What makes Regeneron Pharmaceuticals unique

  • Regeneron leverages proprietary technologies for innovative treatments in serious diseases.
  • The company collaborates with academic and research institutions to enhance R&D efforts.
  • Regeneron's strategic partnerships enable shared costs and profits in new treatment development.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Wellness Program

Paid Vacation

Equity Awards

Annual Bonuses

Flexible Work Hours